Viraday Tablet: A Revolution in HIV/AIDS Treatment
In the relentless pursuit of combating HIV/AIDS, pharmaceutical advancements have played a pivotal role in enhancing the quality of life for millions. One such remarkable stride in the field of antiretroviral therapy is the Viraday Tablet . Manufactured by the renowned pharmaceutical company Cipla Limited, Viraday Tablet stands as a testament to scientific innovation and unwavering dedication to improving healthcare worldwide. Understanding Viraday: The Pill of Hope Viraday Tablet, bearing the distinguished brand name Viraday, is a potent combination of three active ingredients: Efavirenz IP, Emtricitabine IP, and Tenofovir Disoproxil Fumarate IP. These ingredients, meticulously blended and encapsulated into tablets, have revolutionized the management of HIV infections. Breaking Down the Formulation: A Trinity of Effectiveness Efavirenz IP (600 mg) : Efavirenz, a non-nucleoside reverse transcriptase inhibitor (NNRTI), is a key component in Viraday. It works by hindering the activity of...